| |
IL-1F9 (Human ) ELISA Kit,
Recombinant, Antibody |
| Other names: |
|
|
| Functions: Agonist via the IL-1Rrp2
receptor. Increases IL-6, IL-8 production in epithelial cells |
| |
Interleukin-1 family member 9 stimulates chemokine
production and neutrophil influx in mouse lungs
|
| Interleukin-1 (IL-1) is a
proinflammatory cytokine that signals through the Type I IL-1 receptor
(IL-1RI). Novel IL-1-like cytokines were recently identified. Their
functions in lung disease remain unclear. Interleukin-1 family
member-9 (IL-1F9) is one such IL-1-like cytokine, expressed in the
lungs of humans and mice. IL-1F9 signals through IL-1 receptor-related
protein 2 (IL-1Rrp2/IL-1RL2), which is distinct from IL-1RI. We sought
to determine if IL-1F9 acts as a proinflammatory cytokine in lung
disease. IL-1F9 protein was increased in lung homogenates of house
dust mite-challenged A/J mice compared with controls, and expression
was seen in airway epithelial cells. The intratracheal administration
of recombinant mouse IL-1F9 increased airway hyperresponsiveness and
induced neutrophil influx and mucus production, but not eosinophilic
infiltration in the lungs of mice. In addition, IL-1α protein levels
in bronchoalveolar lavage fluid, chemokines, and chemokine-receptor
mRNA expression in the lungs were increased after the instillation of
intratracheal IL-1F9. Consistent with these changes, NF-κB
transcription factor activity was increased in the lungs of mice
challenged with IL-1F9 and in a macrophage cell line treated with
IL-1F9. These data suggest that IL-1F9 is upregulated during
inflammation, and acts as a proinflammatory cytokine in the lungs. |
| Ramadas RA, et al. Am J Respir Cell Mol
Biol. 2011 Feb;44(2):134-45. Epub 2010 Mar 18 |
IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system
that is active in psoriasis and promotes keratinocyte antimicrobial
peptide expression
|
| IL-1F6, IL-1F8, and IL-1F9 and the
IL-1R6(RP2) receptor antagonist IL-1F5 constitute a novel IL-1
signaling system that is poorly characterized in skin. To further
characterize these cytokines in healthy and inflamed skin, we studied
their expression in healthy control, uninvolved psoriasis, and
psoriasis plaque skin using quantitative RT-PCR and
immunohistochemistry. Expression of IL-1F5, -1F6, -1F8, and -1F9 were
increased 2 to 3 orders of magnitude in psoriasis plaque versus
uninvolved psoriasis skin, which was supported immunohistologically.
Moreover, treatment of psoriasis with etanercept led to significantly
decreased IL-1F5, -1F6, -1F8, and -1F9 mRNAs, concomitant with
clinical improvement. Similarly increased expression of IL-1F5, -1F6,
-1F8, and -1F9 was seen in the involved skin of two mouse models of
psoriasis. Suggestive of their importance in inflamed epithelia, IL-1α
and TNF-α induced IL-1F5, -1F6, -1F8, and -1F9 transcript expression
by normal human keratinocytes. Microarray analysis revealed that these
cytokines induce the expression of antimicrobial peptides and matrix
metalloproteinases by reconstituted human epidermis. In particular,
IL-1F8 increased mRNA expression of human β-defensin (HBD)-2, HBD-3,
and CAMP and protein secretion of HBD-2 and HBD-3. Collectively, our
data suggest important roles for these novel cytokines in inflammatory
skin diseases and identify these peptides as potential targets for
antipsoriatic therapies. |
| Johnston A, et al. J Immunol. 2011 Feb
15;186(4):2613-22. Epub 2011 Jan 17. |
| |
|
Human IL-1F9 ELISA kit enables to detect circulating IL-1F9 |
|
EDTA Plasma Samples
|
IL-1F9 (pg/ml)
|
|
1
|
1912.487
|
|
2 |
745.528
|
|
3
|
578.149
|
|
4
|
721.179
|
|
5
|
157.441
|
|
6
|
213.585
|
|
7
|
477.373
|
|
8
|
122.768
|
|
9
|
316.426 |
|
10 |
29.904 |
|
11
|
168.816 |
|
12
|
15.954 |
|
13 |
446.726 |
|
14
|
374.331 |
|
15 |
389.958 |
|
|
|
|
Code No.: SK00739-01
Size: 96 T
Price: $420.00 USD
Standard Range:156-5000 pg/ml
Dynamic Range:156-5000 pg/ml
Sensitivity: 12 pg/ml
Sample Type: serum, EDTA plasma
Sample requres: 200 ul, 100 ul per well
IntraCV: 6-8%
InterCV: 10-12%
Protocol: PDF |
 |
Code No.: A00739-01-100
Size: 100 ug
Price: $260.00 USD
Host: Rabbit
Antigen: ECD of human IL-1F9 Rec.
Ab Type: Polyclonal IgG
Purification: Protein A
Applications: E, IHC
Working Dilution: IHC 1: 200 (5 ug/ml)
Data Sheet: PDF |
 |
Code No.: 00739-01-100
Size: 100 ug
Price: $360.00 USD
Protein ID:Q9NZH8
Gene ID: 56300
MW: 27 KD
Tag: His Tag on N-Terminus
Expressed: E. Coli
Purity: 90%
Data Sheet: PDF |
|
| Name |
Code No. |
Size |
Price ($) |
| Human IL-1F9/IL-36G ELISA Kit |
SK00739-01 |
96 T |
420.00 |
| Human IL-1F9/IL-36G, recombinant |
|
10 ug |
178.00 |
| Human IL-1F9/IL-36G, recombinant |
|
50 ug |
280.00 |
| Human IL-1F9/IL-36G, recombinant |
|
100 ug |
360.00 |
| Human IL-1F9/IL-36G, recombinant |
|
1 mg |
3200.00 |
| Human IL-1F9/IL-36G Biotinylated |
|
50 ug |
420.00 |
| Anti Human IL-1F9/IL-36G IgG |
|
100 ug |
220.00 |
| Anti Human IL-1F9/IL-36G IgG Biotinylated |
|
50 ug |
420.00 |
| Anti Human IL-1F9/IL-36G Monoclonal IgG |
|
100 ug |
260.00 |
| Anti Human IL-1F9/IL-36G Monoclonal IgG Biotinylated |
|
50 ug |
420.00 |
| Anti Human IL-1F9/IL-36G Monoclonal IgG |
|
100 ug |
260.00 |
| Anti Human IL-1F9/IL-36G Monoclonal IgG |
|
100 ug |
260.00 |
| Anti Human IL-1F9/IL-36G Monoclonal IgG |
|
100 ug |
260.00 |
| Anti Human IL-1F9/IL-36G Monoclonal IgG |
|
100 ug |
260.00 |
| Anti Human IL-1F9/IL-36G Monoclonal IgG |
|
100 ug |
260.00 |
| Anti Human IL-1F9/IL-36G Monoclonal IgG |
|
100 ug |
260.00 |
| Anti Human IL-1F9/IL-36G Monoclonal IgG |
|
100 ug |
260.00 |
| Anti Human IL-1F9/IL-36G Monoclonal IgG |
|
100 ug |
260.00 |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
|